Korea Drug Development Fund
Overview
Korea Drug Development Fund is a government-funded organization that provides funding and comprehensive support for drug developers throughout the entire drug-development cycle.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Genuv Inc. | Dec 2021 | Grant | Lead |
| ImmunAbs Inc. | Jan 2024 | Grant | Co-investor |
| Curogen Technology Co., Ltd. | Jan 2026 | Grant | Co-investor |
| Incurix | Dec 2023 | Grant | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Korea Drug Development Fund based?
Korea Drug Development Fund is headquartered in Seoul, South Korea.
When was Korea Drug Development Fund founded?
Korea Drug Development Fund was founded in 2011.
How many portfolio companies does Korea Drug Development Fund have?
Korea Drug Development Fund has 6 portfolio companies in Caplight's dataset.
What are some companies in Korea Drug Development Fund's portfolio?
Portfolio companies visible on Caplight include Genuv Inc., ImmunAbs Inc., Curogen Technology Co., Ltd., Incurix.
What was Korea Drug Development Fund's most recent investment shown here?
Korea Drug Development Fund's most recent investment in this portfolio sample was in Curogen Technology Co., Ltd. in 2026.
What sectors does Korea Drug Development Fund focus on?
Korea Drug Development Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Korea Drug Development Fund focus on?
Korea Drug Development Fund typically invests at the MultiStage stage.